High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine.

ABSTRACT:

SUBMITTER: Tiso F 

PROVIDER: S-EPMC11695669 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature